CASTLE BIOSCIENCES, INC. Fair Value Adjustment of Warrants
CASTLE BIOSCIENCES, INC. (CSTL) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2021-03-11
- CASTLE BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2020-12-31 was $0.00.
- CASTLE BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2020-03-31 was $0.00.
- CASTLE BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- CASTLE BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2019 was $619.00K, a 127.57% increase from fiscal 2018.
- CASTLE BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2018 was $272.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $0.00 10-K · filed 2021-03-11 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $533.00K derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $533.00K derived: sum of 3 quarters · filed 2021-03-11 | $632.00K derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $533.00K derived: sum of 2 quarters · filed 2021-03-11 | $632.00K derived: sum of 3 quarters · filed 2021-03-11 | $619.00K 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $533.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $632.00K derived: sum of 2 quarters · filed 2020-11-09 | $619.00K 10-Q · filed 2020-11-09 | $619.02K 10-Q · filed 2019-11-12 | $861.54K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $86.00K 10-Q · filed 2020-08-10 | $86.11K 10-Q · filed 2019-09-03 | $328.54K derived: sum of 3 quarters · filed 2020-08-10 | $371.34K derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$13.00K 10-Q · filed 2020-05-11 | $229.54K derived: sum of 2 quarters · filed 2020-05-11 | $272.34K derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $242.54K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $285.34K derived: sum of 2 quarters · filed 2020-03-10 | $272.00K 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $42.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $29.46K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | -$13.34K 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |